BHTG / BioHiTech Global Inc - SEC Filings, Annual Report, Proxy Statement

BioHiTech Global Inc
US ˙ NASDAQ
THIS SYMBOL IS NO LONGER ACTIVE

Basic Stats
LEI 54930077H3GWV8GKWE76
CIK 1590383
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to BioHiTech Global Inc
SEC Filings (Chronological Order)
This page provides a complete, chronological list of SEC Filings, excluding ownership filings which we provide elsewhere.
February 2, 2023 EX-16.1

February 2, 2023

Exhibit 16.1 February 2, 2023 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read the statements made by Renovare Environmental, Inc. under Item 4.01 of its Form 8-K dated January 27, 2023. We agree with the statements concerning our Firm in such Form 8-K; we are not in a position to agree or disagree with other statements of Renovare Environmenta

February 2, 2023 8-K

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 27, 2023 RENOVARE ENVIRONMENTAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.

January 10, 2023 EX-10.4

Amended and Restated Security Agreement, dated December 30, 2022, by and among Renovare Environmental, Inc. and certain wholly owned subsidiaries and Michaelson Capital Special Finance Funds II, L.P.

Exhibit 10.4 AMENDED AND RESTATED SECURITY AGREEMENT DATED AS OF DECEMBER 30, 2022 BY AND AMONG MICHAELSON CAPITAL SPECIAL FINANCE FUND II, L.P., AS NOTEHOLDER AND RENOVARE ENVIRONMENTAL, INC. (F/K/A BIOHITECH GLOBAL, INC.), BHT FINANCIAL, LLC, BIOHITECH AMERICA, LLC, BIOHITECH EUROPE, LTD., E.N.A. RENEWABLES, LLC, AND NEW WINDSOR RESOURCE RECOVERY, LLC, AS GUARANTORS TABLE OF CONTENTS Page 1. Gua

January 10, 2023 EX-10.2

Assumption Agreement, dated December 30, 2022, by and among, TraQiQ, Inc. and Michaelson Capital Special Purpose Finance Fund II, L.P. acknowledged and agreed to by Renovare Environmental, Inc. and certain wholly owned subsidiaries

Exhibit 10.2 ASSUMPTION AGREEMENT THIS ASSUMPTION AGREEMENT (this “Agreement”) is made and entered into as of December 30, 2022 (the “Effective Date”), by and between TraQiQ, Inc., a California corporation (“TraQiQ”) and Michaelson Capital Special Finance Fund II, L.P., a Delaware limited partnership (“MCSFF”), as acknowledged and agreed by Renovare Environmental, Inc. (f/k/a BioHiTech Global, Inc

January 10, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 30, 2022 RENOVARE ENVIRO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 30, 2022 RENOVARE ENVIRONMENTAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I

January 10, 2023 EX-10.3

Guaranty and Suretyship Agreement, dated December 30, 2022, by and among Renovare Environmental, Inc. and certain wholly owned subsidiaries and Michaelson Capital Special Finance Funds II, L.P.

Exhibit 10.3 GUARANTY AND SURETYSHIP AGREEMENT THIS GUARANTY AND SURETYSHIP AGREEMENT (this “Agreement”) is made as of December 30, 2022 by each of Renovare Environmental, Inc. (f/k/a BioHiTech Global, Inc.), a Delaware corporation (“Renovare”), BHT Financial, LLC, a Delaware limited liability company (“BHT Financial”), BioHiTech America, LLC a Delaware limited liability company (“BHT America”), B

January 10, 2023 EX-10.1

Asset Purchase Agreement, dated as of December 30, 2022, by and among TraQiQ, Inc., Renovare Environmental, Inc. and BioHiTech America, LLC

Exhibit 10.1 ASSET PURCHASE AGREEMENT by and among Renovare Environmental, Inc., BioHi Tech America, LLC and TraQiQ, Inc. This ASSET PURCHASE AGREEMENT (this “Agreement”) is made as of December 30, 2022, by and among Renovare Environmental, Inc., a Delaware corporation (“Renovare”) , BioHiTech America, LLC, a Delaware limited liability company (together, with Renovare, the “Sellers”) on the one ha

October 7, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 3, 2022 RENOVARE ENVIRONMENTAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R

September 21, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 15, 2022 RENOVARE ENVIRONMENTAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (

September 13, 2022 EX-10.2

Form of Preferred Stock Purchase Warrant

Exhibit 10.2 FORM OF PREFERRED STOCK PURCHASE WARRANT [NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A

September 13, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 7, 2022 RENOVARE ENVIRONMENTAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I

September 13, 2022 EX-10.5

Registration Rights Agreement by and between the Company and certain investors dated September 7, 2022

Exhibit 10.5 REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (this ?Agreement?), dated as of September 7, 2022, is by and among Renovare Environmental, Inc., a Delaware corporation with offices located at 80 Red Schoolhouse Road, Suite 101, Chestnut Ridge, New York 10977 (the ?Company?), and the undersigned buyers (each, a ?Purchasing Buyer,? and collectively, the ?Purchasing Buye

September 13, 2022 EX-4.2

Amended and Restated Certificate of Designations of Series G Convertible Preferred Stock

Exhibit 4.2 AMENDED AND RESTATED CERTIFICATE OF DESIGNATIONS OF SERIES G CONVERTIBLE PREFERRED STOCK OF RENOVARE ENVIRONMENTAL, INC. I, Brian C. Essman, hereby certify that I am the Chief Financial Officer of Renovare Environmental, Inc. (the ?Company?), a corporation organized and existing under the Delaware General Corporation Law (the ?DGCL?), and further do hereby certify: That pursuant to the

September 13, 2022 EX-10.6

Placement Agency Agreement with Network 1 Financial Securities, Inc. dated August 18, 2022

Exhibit 10.6 August 18, 2022 Anthony Fuller Chief Executive Officer Renovare Environmental, Inc. 80 Red Schoolhouse Rd, Suite 101 Chestnut Ridge, NY 10977 Dear Mr. Fuller: Re: PLACEMENT AGENT?S AGREEMENT This letter (the ?Agreement?) constitutes the agreement between, Newtork 1 Financial Securities, Inc. (?Network?, or the ?Placement Agent?) and Renovare Environmental, Inc., a company incorporated

September 13, 2022 EX-10.3

Form of Series G Common Stock Purchase Warrant

Exhibit 10.3 FORM OF SERIES G COMMON STOCK PURCHASE WARRANT NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE

September 13, 2022 EX-4.4

Amended and Restated Certificate of Designations of Series I Convertible Preferred Stock

Exhibit 4.4 AMENDED AND RESTATED CERTIFICATE OF DESIGNATION OF SERIES I CONVERTIBLE PREFERRED STOCK OF RENOVARE ENVIRONMENTAL, INC. Renovare Environmental, Inc., a corporation organized and existing under the laws of the State of Delaware ("Company"), hereby certifies that the Board of Directors of the Company (the "Board of Directors" or the "Board"), pursuant to authority of the Board of Directo

September 13, 2022 EX-10.1

Securities Purchase and Exchange Agreement by and between the Company and certain investors dated September 7, 2022

Exhibit 10.1 SECURITIES PURCHASE AND EXCHANGE AGREEMENT This SECURITIES PURCHASE AND EXCHANGE AGREEMENT (the ?Agreement?), dated as of September 7, 2022, is by and among Renovare Environmental, Inc., a Delaware corporation with offices located at 80 Red Schoolhouse Road, Suite 101, Chestnut Ridge, New York 10977 (the ?Company?), and each of the investors listed on the Schedule of Purchasing Buyers

September 13, 2022 EX-4.3

Amended and Restated Certificate of Designations of Series H Convertible Preferred Stock

Exhibit 4.3 AMENDED AND RESTATED CERTIFICATE OF DESIGNATIONS OF SERIES H CONVERTIBLE PREFERRED STOCK OF RENOVARE ENVIRONMENTAL, INC. I, Brian C. Essman, hereby certify that I am Chief Financial Officer of Renovare Environmental, Inc. (the ?Company?), a corporation organized and existing under the Delaware General Corporation Law (the ?DGCL?), and further do hereby certify: That pursuant to the aut

September 13, 2022 EX-4.1

Certificate of Designations of Series C-1 Redeemable Preferred Stock

Exhibit 4.1 CERTIFICATE OF DESIGNATION OF SERIES C-1 REDEEMABLE PREFERRED STOCK OF RENOVARE ENVIRONMENTAL, INC. Renovare Environmental, Inc., formerly known as BioHiTech Global, Inc., a Company organized and existing under the laws of the State of Delaware (?Company?), hereby certifies that the Board of Directors of the Company (the ?Board of Directors? or the ?Board?), pursuant to authority of th

September 13, 2022 EX-10.4

Form of Series G-1 Common Stock Purchase Warrant

Exhibit 10.4 FORM OF SERIES G-1 COMMON STOCK PURCHASE WARRANT NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENC

August 16, 2022 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NT 10-Q 1 tm2216727d2nt10q.htm NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 001-36843 NOTIFICATION OF LATE FILING CUSIP NUMBER 09074B107 (Check One): ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K x Form 10-Q ¨ Form N-SAR ¨ Form N-CSR For Period Ended: June 30, 2022 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Re

June 30, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

June 24, 2022 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 17, 2022 RENOVARE ENVIRONMENTAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S

June 24, 2022 EX-99.1

Renovare Environmental Announces Intention to Merge with Harp Renewables and Harp Electric Engineering

Exhibit 99.1 Renovare Environmental Announces Intention to Merge with Harp Renewables and Harp Electric Engineering CHESTNUT RIDGE, N.Y., June 24, 2022 (PRNewswire) ? Renovare Environmental, Inc. (OTCPK:RENO) ("Renovare" or "Company"), a circular economy and sustainability technology services provider for the treatment of organic waste, today announced that it has signed a non-binding letter of in

June 24, 2022 EX-10.01

Letter of Intent dated June 17, 2022.

Exhibit 10.01 RENOVARE ENVIRONMENTAL, INC. 80 Red Schoolhouse Road, Suite 101 Chestnut Ridge, NY 10977 June 17, 2022 Biorenewable Technologies, Inc., dba Harp Renewables 3002 Dow Avenue, Suite 134, Tustin CA, 92780 Attn: Robert Webber Harp Electrical Eng. Limited Kentstown, Navan, County Meath, Ireland 360257 Attn: Shane Finnegan Ladies and Gentlemen: We are pleased to submit this non-binding lett

June 22, 2022 8-K

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 15, 2022 RENOVARE ENVIRONMENTAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S

May 16, 2022 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 001-36843 NOTIFICATION OF LATE FILING CUSIP NUMBER 09074B107 (Check One): ? Form 10-K ? Form 20-F ? Form 11-K x Form 10-Q ? Form N-SAR ? Form N-CSR For Period Ended: March 31, 2022 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report

May 4, 2022 8-K

Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 28, 2022 RENOVARE ENVIRONMENTAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.

May 2, 2022 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No.1) (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ¨ TRANS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No.1) (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36843

April 29, 2022 8-K

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 25, 2022 RENOVARE ENVIRONMENTAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.

April 20, 2022 RW

RENOVARE ENVIRONMENTAL, INC. 80 Red Schoolhouse Roade, Suite 101 Chestnut Ridge, New York, 10977

RENOVARE ENVIRONMENTAL, INC. 80 Red Schoolhouse Roade, Suite 101 Chestnut Ridge, New York, 10977 April 20, 2022 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Renovare Environmental, Inc. Application for Withdrawal of Registration Statement on Form S-3 Filed February 7, 2022 Ladies and Gentlemen: Pursuant to

April 15, 2022 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ⌧ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ◻ TRANSITION REPORT PURSUA

Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

April 15, 2022 EX-21.1

List of Subsidiaries.*

Exhibit 21.1 ? Subsidiaries ? December 31, 2021 Ownership Subsidiaries of Renovare Environmental, Inc.: ? ? ? Bio Hi Tech America, LLC (Delaware limited liability company) ? 100 % ? ? ? ? BioHiTech Europe Limited (A private company limited by shares registered in England and Wales) ? 100 % ? ? ? ? E.N.A Renewables LLC (Delaware limited liability company) ? 100 % ? ? ? ? BHT Financial LLC (Delaware

March 31, 2022 NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NT 10-K 1 tm2210995d1nt10k.htm NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 001-36843 NOTIFICATION OF LATE FILING CUSIP NUMBER 09074B107 (Check One): x Form 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form N-SAR ¨ Form N-CSR For Period Ended: December 31, 2021 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transitio

March 29, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 24, 2022 RENOVARE ENVIRONMENTAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.

March 24, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 18, 2022 RENOVARE ENVIRONMENTAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.

March 17, 2022 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 17, 2022 RENOVARE ENVIRONMENTAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.

March 17, 2022 EX-99.1

HARP Acquisition March 2022

Exhibit 99.1 HARP Acquisition March 2022 Forward Looking Statement & Safe Harbor This presentation has been prepared by Renovare Environmental, Inc . , formerly BioHiTech Global, Inc . (?Renovare? or the ?Company?) and includes information from other sources believed by management to be reliable . No representation or warranty, express or implied, is made as to the accuracy or completeness of any

March 4, 2022 EX-10.1

Form of Agreement of Purchase and Sale Biorenewable Technologies, Inc.. dated February 28, 2022*

Exhibit 10.1 AGREEMENT OF PURCHASE AND SALE dated as of February 28, 2022 BIORENEWABLE TECHNOLOGIES, INC. AGREEMENT OF PURCHASE AND SALE THIS AGREEMENT (this ?Agreement?) is made and entered into as of February 28, 2022 (the ?Effective Date?), by and among: (i) BIORENEWABLE TECHNOLOGIES, INC., a Delaware corporation (the ?Company?); (ii) the shareholders of the Company identified on Annex A annexe

March 4, 2022 8-K

Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 28, 2022 RENOVARE ENVIRONMENTAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I

March 4, 2022 EX-99.1

Renovare Environmental to Acquire Harp Renewables Company Expected to be EBITDA and Cash Flow Positive by FY2023 Acquisition Accelerates Company’s Growth in Europe and North America Stock and Cash Transaction Expected to Create Significant Synergies

Exhibit 99.1 RENOVARE ENVIRONMENTAL, Inc. 80 Red Schoolhouse Road, Suite 101 Chestnut Ridge, NY 10977 Renovare Environmental to Acquire Harp Renewables Company Expected to be EBITDA and Cash Flow Positive by FY2023 Acquisition Accelerates Company’s Growth in Europe and North America Stock and Cash Transaction Expected to Create Significant Synergies Combined Product Lineup Provides Most Expansive

March 4, 2022 EX-10.2

Form of Sale and Purchase of Entire Share Capital of Harp Electric Eng. Limited dated February 28, 2022 (filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on March 4, 2022).

Exhibit 10.2 AGREEMENT FOR THE SALE AND PURCHASE OF THE ENTIRE ISSUED SHARE CAPITAL OF HARP ELECTRICAL ENG. LIMITED BRT HoldCo Inc. BioRenewable Technologies, Inc. DATED 28 FEBRUARY 2022 Table of Contents 1 DEFINITIONS AND INTERPRETATION 3 2 SALE AND PURCHASE OF SHARES, ADJUSTMENT OF CONSIDERATION 10 3 CONDITIONS TO COMPLETION 12 4 PERIOD PENDING COMPLETION 13 5 COMPLETION 14 6 WARRANTIES 16 7 COV

February 7, 2022 EX-FILING FEES

Filing Fee Table *

Exhibit 107 EX-FILING FEES Calculation of Filing Fee Tables F0RM S-3 REGISTRATION STATEMENT (Form Type) RENOVARE ENVIRONMENTAL.

February 7, 2022 S-3

As filed with the Securities and Exchange Commission on February 7, 2022

As filed with the Securities and Exchange Commission on February 7, 2022 Registration No.

January 26, 2022 EX-10.1

Form of Securities Purchase Agreement (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on January 26, 2022).

Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this ?Agreement?) is dated as of January 21, 2022, between Renovare Environmental Inc., a Delaware corporation (the ?Company?), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a ?Purchaser? and collectively, the ?Purchasers?). WHEREAS, subject to the terms and con

January 26, 2022 EX-99.1

Renovare Environmental, Inc. Announces Pricing of $1.3 Million Private Placement

Exhibit 99.1 RENOVARE ENVIRONMENTAL, Inc. 80 Red Schoolhouse Road, Suite 101 Chestnut Ridge, NY 10977 Renovare Environmental, Inc. Announces Pricing of $1.3 Million Private Placement CHESTNUT RIDGE, N.Y., January, 21, 2022 /PRNewswire/ - Renovare Environmental, Inc. (the "Company") (NASDAQ: RENO), a circular economy and sustainability technology and services provider, today announced that it enter

January 26, 2022 EX-10.3

Form of Registration Rights Agreement dated January 21, 2027 (filed as Exhibit 10.3 to the Company’s Current Report on Form 8-K filed on January 26, 2022).

Exhibit 10.3 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this ?Agreement?) is made and entered into as of January 21, 2022, between Renovare Environmental, Inc., a Delaware corporation (the ?Company?), and each of the several purchasers signatory hereto (each such purchaser, a ?Purchaser? and, collectively, the ?Purchasers?). This Agreement is made pursuant to the Securities

January 26, 2022 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 21, 2022 RENOVARE ENVIRONMENTAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.

January 26, 2022 EX-99.2

Renovare Environmental, Inc. Announces Closing of $1.3 Million Private Placement

Exhibit 99.2 RENOVARE ENVIRONMENTAL, Inc. 80 Red Schoolhouse Road, Suite 101 Chestnut Ridge, NY 10977 Renovare Environmental, Inc. Announces Closing of $1.3 Million Private Placement CHESTNUT RIDGE, N.Y., Jan. 25, 2022 /PRNewswire/ - Renovare Environmental, Inc. (the "Company") (NASDAQ: RENO), a circular economy and sustainability technology and services provider, today announced the closing of it

January 26, 2022 EX-10.4

Form of Agreement of Purchase and Sale Biorenewable Technologies, Inc.. dated February 28, 2022 (filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on March 4, 2022).

Exhibit 10.4 ? NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY?NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGI

January 26, 2022 EX-10.2

Form of Placement Agency Agreement dated January 21, 2027 (filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on January 26, 2022).

Exhibit 10.2 January 21, 2022 Renovare Environmental, Inc. 80 Red Schoolhouse Road, Suite 101 Chestnut Ridge, NY 10977 Attention: Brian C. Essman, Chief Financial Officer Dear Mr. Essman: This letter (the ?Agreement?) constitutes the agreement between EF Hutton, division of Benchmark Investments, LLC (?EF Hutton? or the ?Placement Agent?) and Renovare Environmental, Inc. (the ?Company?), that EF H

January 18, 2022 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 12, 2022 RENOVARE ENVIRONMENTAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.

January 11, 2022 8-K

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 10, 2022 RENOVARE ENVIRONMENTAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.

December 14, 2021 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 13, 2021 RENOVARE ENVIRONMENTAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I

December 14, 2021 EX-3.1

Press release, dated December 13, 2021, entitled “BioHiTech Global Rebrands to Renovare Environmental, Inc.

Exhibit 3.1 BIOHITECH GLOBAL, Inc. 80 Red Schoolhouse Road, Suite 101 Chestnut Ridge, NY 10977 BIOHITECH GLOBAL REBRANDS TO RENOVARE ENVIRONMENTAL, INC. Company to be traded on Nasdaq under symbol RENO effective December 13, 2021 Management believes new identification better in line with Company?s current operations, vision, and mission statement CHESTNUT RIDGE, NY ? December 13, 2021 ? BioHiTech

December 10, 2021 EX-3.1

Certificate of Amendment to Certificate of Incorporation dated December 6, 2021 (previously filed as Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on December 10, 2021).

Exhibit 3.1 CERTIFICATE OF AMENDMENT OF THE CERTIFICATE OF INCORPORATION OF BIOHITECH GLOBAL, INC. Under Section 242 of the General Corporation Law) It is hereby certified that: 1. The name of the corporation is BioHiTech Global, Inc. (hereinafter referred to as the ?Corporation?). 2. The Certificate of Incorporation of the Corporation is hereby amended by striking out Article FIRST thereof and by

December 10, 2021 8-K

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 6, 2021 RENOVARE ENVIRONMENTAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.

November 19, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 18, 2021 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S.

November 19, 2021 EX-99.1

BIOHITECH GLOBAL REPORTS RECORD RESULTS WITH THIRD QUARTER REVENUE UP OVER 500% FROM YEAR-AGO PERIOD Fourth Consecutive Quarter of Record Revenue Conference Call to be held Thursday, November 18, 2021, at 4:30 pm

Exhibit 99.1 BIOHITECH GLOBAL, Inc. 80 Red Schoolhouse Road, Suite 101 Chestnut Ridge, NY 10977 BIOHITECH GLOBAL REPORTS RECORD RESULTS WITH THIRD QUARTER REVENUE UP OVER 500% FROM YEAR-AGO PERIOD Fourth Consecutive Quarter of Record Revenue Conference Call to be held Thursday, November 18, 2021, at 4:30 pm CHESTNUT RIDGE, NY ? November 18, 2021 ? BioHiTech Global, Inc. (?BioHiTech? or the ?Compan

November 18, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

November 15, 2021 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 001-36843 NOTIFICATION OF LATE FILING CUSIP NUMBER 09074B107 (Check One): ? Form 10-K ? Form 20-F ? Form 11-K x Form 10-Q ? Form N-SAR ? Form N-CSR For Period Ended: September 30, 2021 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Rep

November 12, 2021 424B1

BIOHITECH GLOBAL, INC. 7,000,000 Shares OF COMMON STOCK

Filed Pursuant to Rule 424(b)(1) Registration No: 333-260433 PROSPECTUS BIOHITECH GLOBAL, INC.

October 29, 2021 CORRESP

October 29, 2021

October 29, 2021 Via Edgar Only Ryan Lichtenfels Division of Corporate Finance Office of Trade & Services United States Securities and Exchange Commission Washington, D.

October 22, 2021 S-1

As filed with the Securities and Exchange Commission on October 22, 2021

As filed with the Securities and Exchange Commission on October 22, 2021 Registration No.

September 24, 2021 EX-10.2

Registration Rights Agreement between the Company and Keystone Capital Partners, LLC, dated September 23, 2021 (filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on September 24, 2021).

Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (this ?Agreement?), dated as of September 23, 2021, is by and between Keystone Capital Partners, LLC, a Delaware limited liability company (the ?Investor?), and BioHiTech Global, Inc., a Delaware corporation (the ?Company?). RECITALS A. The Company and the Investor have entered into that certain Common Stock Purchase Agr

September 24, 2021 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 23, 2021 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S.

September 24, 2021 EX-10.1

Common Stock Purchase Agreement by and between the Company and Keystone dated September 23, 2021

Exhibit 10.1 COMMON STOCK PURCHASE AGREEMENT Dated as of September 23, 2021 by and between BIOHITECH GLOBAL, INC. and KEYSTONE CAPITAL PARTNERS, LLC Table of Contents Page Article I DEFINITIONS 1 Article II PURCHASE AND SALE OF COMMON STOCK 2 Section 2.1. Purchase and Sale of Stock 2 Section 2.2. Closing Date; Settlement Dates 2 Section 2.3. Initial Public Announcements and Required Filings 2 Arti

September 13, 2021 EX-99.1

Corporate Presentation September 2021 Nasdaq: BHTG

Exhibit 99.1 Corporate Presentation September 2021 Nasdaq: BHTG This presentation has been prepared by BioHiTech Global, Inc . (?BioHiTech? or the ?Company?) and includes information from other sources believed by management to be reliable . No representation or warranty, express or implied, is made as to the accuracy or completeness of any of the information set forth herein . This presentation m

September 13, 2021 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 13, 2021 BIOHITECH GLOB

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 13, 2021 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S.

September 1, 2021 8-K

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 26, 2021 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S. Em

August 10, 2021 EX-99.1

BIOHITECH GLOBAL REPORTS SECOND QUARTER 2021 FINANCIAL RESULTS WITH RECORD REVENUE Third Consecutive Quarter of Record Revenue Conference Call to be held Today, August 9, 2021, at 4:30pm

Exhibit 99.1 BIOHITECH GLOBAL, Inc. 80 Red Schoolhouse Road, Suite 101 Chestnut Ridge, NY 10977 BIOHITECH GLOBAL REPORTS SECOND QUARTER 2021 FINANCIAL RESULTS WITH RECORD REVENUE Third Consecutive Quarter of Record Revenue Conference Call to be held Today, August 9, 2021, at 4:30pm CHESTNUT RIDGE, NY ? August 9, 2021 ? BioHiTech Global, Inc. (?BioHiTech? or the ?Company?) (NASDAQ: BHTG), a sustain

August 10, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 9, 2021 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S. Emp

August 9, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

August 3, 2021 DEFA14A

Our Amended Definitive Proxy Statement on Schedule 14A filed on August 3, 2021

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State

August 3, 2021 8-K

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 29, 2021 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S. Empl

May 18, 2021 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 17, 2021 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S. Emplo

May 18, 2021 EX-99.1

BIOHITECH GLOBAL REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE Conference Call to be held Monday, May 17, 2021 at 4:30pm

Exhibit 99.1 BIOHITECH GLOBAL, Inc. 80 Red Schoolhouse Road, Suite 101 Chestnut Ridge, NY 10977 BIOHITECH GLOBAL REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE Conference Call to be held Monday, May 17, 2021 at 4:30pm CHESTNUT RIDGE, NY ? May 17, 2021 ? BioHiTech Global, Inc. (?BioHiTech? or the ?Company?) (NASDAQ: BHTG), a sustainable technology and services company, t

May 18, 2021 EX-99.1

BioHiTech Confirms Approximately $2.3 Million in New Food Waste Digester Orders for 16 Additional Ships from Carnival Corporation

Exhibit 99.1 BIOHITECH GLOBAL, Inc. 80 Red Schoolhouse Road, Suite 101 Chestnut Ridge, NY 10977 BioHiTech Confirms Approximately $2.3 Million in New Food Waste Digester Orders for 16 Additional Ships from Carnival Corporation CHESTNUT RIDGE, NY ? May 18, 2021 ? BioHiTech Global, Inc. (?BioHiTech? or the ?Company?) (NASDAQ: BHTG), a sustainable technology and environmental solutions company, announ

May 18, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 17, 2021 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S. Emplo

May 17, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-36843 BIOHITECH GLOBAL, IN

April 29, 2021 DEF 14A

Definitive Proxy Statement on Schedule 14A, as amended, originally filed on July 29, 2021

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy State

April 19, 2021 EX-99.1

BIOHITECH GLOBAL REPORTS YEAR-END 2020 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE Conference Call to be held Tuesday April 20, 2021 at 4:30pm

Exhibit 99.1 BIOHITECH GLOBAL, Inc. 80 Red Schoolhouse Road, Suite 101 Chestnut Ridge, NY 10977 BIOHITECH GLOBAL REPORTS YEAR-END 2020 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE Conference Call to be held Tuesday April 20, 2021 at 4:30pm CHESTNUT RIDGE, NY ? April 16, 2021 ? BioHiTech Global, Inc. (?BioHiTech? or the ?Company?) (NASDAQ: BHTG), a sustainable technology and services company, to

April 19, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 16, 2021 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S. Emp

April 16, 2021 10-K

Annual Report - FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36843 BioHiTech Global,

April 16, 2021 EX-21.1

List of Subsidiaries.*

Exhibit 21.1 Subsidiaries ? December 31, 2020 Ownership Subsidiaries of BioHiTech Global, Inc.: Bio Hi Tech America, LLC (Delaware limited liability company) 100 % BioHiTech Europe Limited (A private company limited by shares registered in England and Wales) 100 % E.N.A Renewables LLC (Delaware limited liability company) 100 % BHT Financial LLC (Delaware limited liability company) 100 % Apple Vall

March 31, 2021 NT 10-K

- NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SEC FILE NUMBER 001-36843 FORM 12b-25 CUSIP NUMBER NOTIFICATION OF LATE FILING 09074B107 (Check One): x Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form N-SAR ? Form N-CSR For Period Ended: December 31, 2020 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Repo

February 22, 2021 EX-1.1

At Market Issuance Sales Agreement by and between BioHiTech Global, Inc. and B. Riley Securities, Inc. dated February 19, 2021 (filed as Exhibit 1.1 to the Company’s Current Report on Form 8-K filed on February 22, 2021)

EXHIBIT 1.1 BioHiTech Global, Inc. Common Stock (par value $0.0001 per share) At Market Issuance Sales Agreement February 19, 2021 B. Riley Securities, Inc. 299 Park Avenue, 21st Floor New York, NY 10171 Ladies and Gentlemen: BioHiTech Global, Inc., a Delaware corporation (the ?Company?), confirms its agreement (this ?Agreement?) with B. Riley Securities, Inc. (the ?Agent?) as follows: 1. Issuance

February 22, 2021 424B5

BIOHITECH GLOBAL, INC. Up to $11,150,000 of Shares of Common Stock

PROSPECTUS SUPPLEMENT Filed Pursuant to Rule 424(b)(5) (to Prospectus dated July 11, 2018) Registration No.

February 22, 2021 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 19, 2021 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S.

January 19, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 12, 2021 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S. E

December 17, 2020 EX-99.1

Smart Technologies Driving Positive Environmental Change Investor Presentation December 2020 BioHiTech Global Inc. Nasdaq: BHTG

Exhibit 99.1 Smart Technologies Driving Positive Environmental Change Investor Presentation December 2020 BioHiTech Global Inc. Nasdaq: BHTG This presentation has been prepared by BioHiTech Global, Inc . (“BioHiTech” or the “Company”) and includes information from other sources believed by management to be reliable . No representation or warranty, express or implied, is made as to the accuracy or

December 17, 2020 8-K

Regulation FD Disclosure, Financial Statements and Exhibits - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 17, 2020 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S.

November 20, 2020 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 19, 2020 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S.

November 20, 2020 EX-99.1

BioHiTech Global Reports Third Quarter 2020 Financial Results Conference call to be held today, November 19, at 4:30 p.m. Eastern Time

Exhibit 99.1 BioHiTech Global Reports Third Quarter 2020 Financial Results Conference call to be held today, November 19, at 4:30 p.m. Eastern Time CHESTNUT RIDGE, NY – November 19, 2020 – BioHiTech Global, Inc. (“BioHiTech” or the “Company”) (NASDAQ: BHTG), a sustainable technology and services company, today announces financial results for its third quarter 2020 ended September 30, 2020. Third Q

November 19, 2020 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2020 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-36843 BIOHITECH GLOBAL

November 16, 2020 NT 10-Q

- NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SEC FILE NUMBER 001-36843 FORM 12b-25 CUSIP NUMBER NOTIFICATION OF LATE FILING 09074B107 (Check One): ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K x Form 10-Q ¨ Form N-SAR ¨ Form N-CSR For Period Ended: September 30, 2020 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Rep

November 6, 2020 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

8-K 1 tm2035312d18k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 5, 2020 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (

November 6, 2020 EX-99.1

BioHiTech Global Appoints Anthony Fuller as Chief Executive Officer

Exhibit 99.1 BioHiTech Global Appoints Anthony Fuller as Chief Executive Officer Former Walmart executive to focus on transformational growth CHESTNUT RIDGE, N.Y., Nov. 5, 2020 /PRNewswire/ - BioHiTech Global, Inc. ("BioHiTech" or the "Company") (NASDAQ: BHTG), a sustainable technology and services company, announces today the appointment by its Board of Directors of Anthony (Tony) Fuller as Chief

October 23, 2020 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 19, 2020 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S. E

October 23, 2020 EX-4.1

Form of Common Stock Purchase Warrant (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on October 23, 2020)

Exhibit 4.1 THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF A REGISTRATION STATEMENT IN EFFECT WITH RESPECT TO SUCH SECURITIES UNDER SUCH ACT AND QUALIFICATION U

October 23, 2020 EX-99.1

BioHiTech Global Makes Strategic Investment in Rensselaer, NY Land Venture as Material Step Towards Establishing a Renewable Energy Campus including New York State's First Waste Conversion Facility Supportive of New York's efforts to bolster Governor

EX-99.1 4 tm2034178d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 BioHiTech Global Makes Strategic Investment in Rensselaer, NY Land Venture as Material Step Towards Establishing a Renewable Energy Campus including New York State's First Waste Conversion Facility Supportive of New York's efforts to bolster Governor Cuomo's plans for increasing renewable energy projects and creating positive impacts on cli

October 23, 2020 EX-10.1

Membership Interest Purchase Agreement (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on October 23, 2020)

Exhibit 10.1 MEMBERSHIP INTEREST PURCHASE AGREEMENT This MEMBERSHIP INTEREST PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of this 15th day of October, 2020 (the “Effective Date”), by and among BHT Renewables, LLC f/k/a E.N.A. Renewables LLC, a Delaware limited liability company and wholly owned subsidiary of BioHitech Global, Inc., a Delaware business corporation (“Buyer”), EA

August 17, 2020 EX-99.1

BioHiTech Global Reports Second Quarter 2020 Financial Results Q2 2020 revenues increase by 21.2% to $1.3 million compared to $1.1 million in Q2 2019

Exhibit 99.1 BIOHITECH GLOBAL, Inc. 80 Red Schoolhouse Road, Suite 101 Chestnut Ridge, NY 10977 BioHiTech Global Reports Second Quarter 2020 Financial Results Q2 2020 revenues increase by 21.2% to $1.3 million compared to $1.1 million in Q2 2019 CHESTNUT RIDGE, NY – August 17, 2020 – BioHiTech Global, Inc. (“BioHiTech” or the “Company”) (NASDAQ: BHTG), a technology and services company that provid

August 17, 2020 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 17, 2020 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S. Em

August 14, 2020 10-Q

Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2020 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-36843 BIOHITECH GLOBAL, INC

July 30, 2020 EX-99.1

BioHiTech Global, Inc. Announces Closing of $8.2 Million Underwritten Public Offering

Exhibit 99.1 BioHiTech Global, Inc. Announces Closing of $8.2 Million Underwritten Public Offering CHESTNUT RIDGE, N.Y., – July 29 2020 – BioHiTech Global, Inc., (Nasdaq: BHTG) (“BioHiTech,” or the “Company”), a technology and services company that provides cost-effective and sustainable waste management solutions, today announced it closed its previously announced underwritten public offering of

July 30, 2020 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 27, 2020 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S. Empl

July 30, 2020 EX-10.2

Form of Underwriter Warrant (filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on July 30, 2020)

Exhibit 10.2 REPRESENTATIVE COMMON STOCK PURCHASE WARRANT BIOHITECH GLOBAL, INC. Warrant Shares: Initial Exercise Date: January 25, 2021 THIS REPRESENTATIVE COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or

July 30, 2020 EX-10.1

Underwriting Agreement with Maxim Group, LLC. dated July 27, 2020 (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on July 30, 2020)

Exhibit 10.1 4,550,000 SHARES of Common Stock BIOHITECH GLOBAL, INC. UNDERWRITING AGREEMENT July 27, 2020 Maxim Group LLC As the Representative of the Several underwriters, if any, named in Schedule I hereto c/o Maxim Group LLC 405 Lexington Avenue New York, NY 10174 Ladies and Gentlemen: The undersigned, BioHiTech Global, Inc., a company incorporated under the laws of Delaware (collectively with

July 29, 2020 424B5

BIOHITECH GLOBAL, INC. 4,550,000 Shares of Common Stock

Filed Pursuant to Rule 424(b)(5) Registration No. 333-225999 PROSPECTUS SUPPLEMENT (To the Prospectus dated June 29, 2018) BIOHITECH GLOBAL, INC. 4,550,000 Shares of Common Stock BioHiTech Global, Inc. is offering 4,550,000 shares of common stock, par value $0.0001 per share (the “Common Stock”) at a price of $1.81 per share (the “Offering”). We will receive gross proceeds of $8,235,500 from this

July 29, 2020 8-K

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 23, 2020 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S. Empl

July 29, 2020 424B5

BIOHITECH GLOBAL, INC. 4,550,000 Shares of Common Stock

Filed Pursuant to Rule 424(b)(5) Registration No. 333-225999 AMENDMENT NO. 1 TO PROSPECTUS SUPPLEMENT (To the Prospectus dated June 29, 2018) BIOHITECH GLOBAL, INC. 4,550,000 Shares of Common Stock BioHiTech Global, Inc. is offering 4,550,000 shares of common stock, par value $0.0001 per share (the “Common Stock”) at a price of $1.81 per share (the “Offering”). We will receive gross proceeds of $8

July 27, 2020 424B5

BIOHITECH GLOBAL, INC. _________ Shares of Common Stock

Filed Pursuant to Rule 424(b)(5) Registration No. 333-225999 The information in this preliminary prospectus supplement is not complete and may be changed. A registration statement relating to the securities has become effective under the Securities Act of 1933. This preliminary prospectus supplement and the accompanying prospectus are not offers to sell these securities and are not soliciting an o

July 17, 2020 EX-99.1

Smart Disposal Technologies Driving Positive Environmental Change Investor Presentation July 2020 BioHiTech Global Nasdaq: BHTG

EX-99.1 2 tm2025072d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Smart Disposal Technologies Driving Positive Environmental Change Investor Presentation July 2020 BioHiTech Global Nasdaq: BHTG This presentation has been prepared by BioHiTech Global, Inc . (the ‘Company’) and includes information from other sources believed by management to be reliable . No representation or warranty, express or implied,

July 17, 2020 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 17, 2020 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S. Empl

July 13, 2020 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 9, 2020 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S. Emplo

July 13, 2020 EX-99.1

BioHiTech Global Appoints Walter Littlejohn III as an Independent Member of Its Board of Directors

Exhibit 99.1 BIOHITECH GLOBAL, Inc. 80 Red Schoolhouse Road, Suite 101 Chestnut Ridge, NY 10977 FOR IMMEDIATE RELEASE BioHiTech Global Appoints Walter Littlejohn III as an Independent Member of Its Board of Directors CHESTNUT RIDGE, NY – July 10, 2020 – BioHiTech Global, Inc. (“BioHiTech” or the “Company”) (NASDAQ: BHTG), a technology and services company that provides cost-effective and sustainab

July 6, 2020 EX-10.1

BHT Financial LLC, (Comerica) Amendment No. 2 to Credit Agreement, June 30, 2020 (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on July 6, 2020)

Exhibit 10.1 AMENDMENT NO. 2 TO CREDIT AGREEMENT This Amendment No. 2 to Credit Agreement (“Amendment”) is made on June , 2020 (“Amendment No. 2 Effective Date”) between BHT FINANCIAL LLC, a Delaware limited liability company (“Borrower”), and Comerica Bank, a Texas banking association (“Bank”). Borrower and Bank entered into a Credit Agreement dated February 2, 2018, as amended by Amendment No. 1

July 6, 2020 EX-10.2

BHT Financial LLC, (Comerica) Master Revolving Note, June 30, 2020 (filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on July 6, 2020)

Exhibit 10.2 Master Revolving Note LIBOR-based Rate Demand-Optional Advances (Business and Commercial Loans Only) AMOUNT NOTE DATE MATURITY DATE $1,500,000.00 June 30, 2020 ON DEMAND 1. ON DEMAND (or as otherwise provided in this Note), FOR VALUE RECEIVED, the undersigned, BHT FINANCIAL LLC, a Delaware limited liability company, promises to pay to the order of COMERICA BANK (herein called “Bank”),

July 6, 2020 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 30, 2020 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S. Empl

June 30, 2020 NT 10-Q

- NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SEC FILE NUMBER 001-36843 FORM 12b-25 CUSIP NUMBER NOTIFICATION OF LATE FILING 09074B107 (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K x Form 10-Q ☐ Form N-SAR ☐ Form N-CSR For Period Ended: March 31, 2020 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report

June 30, 2020 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 tm2023856d18k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 30, 2020 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Com

June 30, 2020 10-Q

Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2020 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-36843 BIOHITECH GLOBAL, IN

June 30, 2020 EX-99.1

BioHiTech Global Reports First Quarter 2020 Financial Results Q1 2020 revenues increase by 84.3% to $1.4 million compared to $738,000 in Q1 2019

Exhibit 99.1 BIOHITECH GLOBAL, Inc. 80 Red Schoolhouse Road, Suite 101 Chestnut Ridge, NY 10977 BioHiTech Global Reports First Quarter 2020 Financial Results Q1 2020 revenues increase by 84.3% to $1.4 million compared to $738,000 in Q1 2019 CHESTNUT RIDGE, NY – June 30, 2020 – BioHiTech Global, Inc. (“BioHiTech” or the “Company”) (NASDAQ: BHTG), a technology and services company that provides cost

June 4, 2020 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

8-K 1 tm2021862d18k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 3, 2020 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Comm

May 27, 2020 EX-99.1

BioHiTech Global Reports Full Year 2019 Results Full year revenues increase by 25.6% to $4.2 million compared to $3.4 million in 2018

Exhibit 99.1 BIOHITECH GLOBAL, Inc. 80 Red Schoolhouse Road, Suite 101 Chestnut Ridge, NY 10977 BioHiTech Global Reports Full Year 2019 Results Full year revenues increase by 25.6% to $4.2 million compared to $3.4 million in 2018 CHESTNUT RIDGE, NY – May 26, 2020 – BioHiTech Global, Inc. (“BioHiTech” or the “Company”) (NASDAQ: BHTG), a technology and services company that provides cost-effective a

May 27, 2020 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 26, 2020 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S. Emplo

May 22, 2020 10-K

Annual Report - FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36843 BioHiTech Global,

May 22, 2020 EX-21.1

List of Subsidiaries.*

Exhibit 21.1 Subsidiaries – December 31, 2019 Ownership Subsidiaries of BioHiTech Global, Inc.: Bio Hi Tech America, LLC (Delaware limited liability company) 100 % BioHiTech Europe Limited (A private company limited by shares registered in England and Wales) 100 % E.N.A Renewables LLC (Delaware limited liability company) 100 % BHT Financial LLC (Delaware limited liability company) 100 % Apple Vall

May 14, 2020 EX-10.2

Note under the SBA Paycheck Protection Program dated May 12, 2020 of BioHiTech America, LLC and Comerica Bank (previously filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K filed May 14, 2020 and incorporated herein by reference).

Exhibit 10.2 DocuSign Envelope ID: 2456EB4B-862B-4AFD-A3F8-4EE70653C56B U.S. Small Business Administration NOTE 1. PROMISE TO PAY: In return for the Loan, Borrower promises to pay to the order of Lender the amount of $ 421,300 , interest on the unpaid principal balance, and all other amounts required by this Note. 2. DEFINITIONS: “Loan” means the loan evidenced by this Note. “Loan Documents” means

May 14, 2020 EX-10.1

Loan Agreement under the SBA Paycheck Protection Program dated May 12, 2020 of BioHiTech America, LLC and Comerica Bank (previously filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed May 14, 2020 and incorporated herein by reference).

Exhibit 10.1 DocuSign Envelope ID: 2456EB4B-862B-4AFD-A3F8-4EE70653C56B LOAN AGREEMENT THIS LOAN AGREEMENT, made and entered into this 10 day of May , 2020, (this “Loan Agreement”) is by and between Bio Hi Tech America,LLC (collectively, “Borrower”) and COMERICA BANK (“Lender”). W I T N E S S E T H WHEREAS, of even date herewith, Lender and Borrower have entered into that certain U.S. Small Busine

May 14, 2020 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 12, 2020 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S. Emplo

May 6, 2020 DEFR14A

May 6, 2020

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Amendment No. 1) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defi

April 29, 2020 DEF 14A

- DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive

April 14, 2020 8-K

Other Events

8-K 1 tm2015792d18k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 30, 2020 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Co

March 30, 2020 NT 10-K

BHTG / BioHiTech Global, Inc. NT 10-K - - NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SEC FILE NUMBER 001-36843 FORM 12b-25 CUSIP NUMBER NOTIFICATION OF LATE FILING 09074B107 (Check One): x Form 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form N-SAR ¨ Form N-CSR For Period Ended: December 31, 2019 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Repo

March 18, 2020 EX-10.2

Form of Common Stock Purchase Warrant to be issued together with the Registrant’s Series F Redeemable, Convertible Preferred Stock and Warrants (previously filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K filed March 18, 2020 and incorporated herein by reference).

Exhibit 10.2 THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF A REGISTRATION STATEMENT IN EFFECT WITH RESPECT TO SUCH SECURITIES UNDER SUCH ACT AND QUALIFICATION

March 18, 2020 EX-10.1

Form of Securities Purchase Agreement of the Registrant’s Series F Redeemable, Convertible Preferred Stock and Warrants (previously filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed March 18, 2020 and incorporated herein by reference).

Exhibit 10.1 SECURITIES PURCHASE AGREEMENT THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of March , 2020, is entered into by and between BioHiTech Global, Inc., a Delaware corporation, (the “Company”) and each purchaser identified on a signature page of the Agreement (each a “Purchaser”, and collectively, the “Purchasers”). WITNESSETH: WHEREAS, the Company and the Purchaser are ex

March 18, 2020 EX-4.1

Certificate of Designation of Series F Redeemable, Convertible Preferred Stock of BioHiTech Global, Inc. (previously filed as Exhibit 4.1 on the Current Report on Form 8-K filed March 18, 2020 and incorporated herein by reference).

Exhibit 4.1 CERTIFICATE OF DESIGNATION OF SERIES F REDEEMABLE, CONVERTIBLE PREFERRED STOCK OF BIOHITECH GLOBAL, INC. BioHiTech Global, Inc., a corporation organized and existing under the laws of the State of Delaware ("Company"), hereby certifies that the Board of Directors of the Company (the "Board of Directors" or the "Board"), pursuant to authority of the Board of Directors as required by app

March 18, 2020 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 18, 2020 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S. Emp

March 9, 2020 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 1, 2020 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S. Empl

March 9, 2020 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 5, 2020 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S. Empl

March 9, 2020 EX-99.1

BioHiTech Global Appoints Tony Fuller to the Newly Created Position of Chief Administrative Officer

EX-99.1 3 tm2012012d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 BIOHITECH GLOBAL, Inc. 80 Red Schoolhouse Road, Suite 101 Chestnut Ridge, NY 10977 BioHiTech Global Appoints Tony Fuller to the Newly Created Position of Chief Administrative Officer CHESTNUT RIDGE, NY – March 5, 2020 – BioHiTech Global, Inc. (“BioHiTech” or the “Company”) (NASDAQ: BHTG), a technology and services company that provides cost

March 9, 2020 EX-99.1

Smart Disposal Technologies Driving Positive Environmental Change Investor Presentation March 2020 BioHiTech Global Nasdaq: BHTG

Exhibit 99.1 Smart Disposal Technologies Driving Positive Environmental Change Investor Presentation March 2020 BioHiTech Global Nasdaq: BHTG This presentation has been prepared by BioHiTech Global, Inc . (the ‘Company’) and includes information from other sources believed by management to be reliable . No representation or warranty, express or implied, is made as to the accuracy or completeness o

March 9, 2020 EX-10.1

Offer of Employment dated February 28, 2020

Exhibit 10.1 80 Red Schoolhouse Road Suite 101 Chestnut Ridge, NY 10977 Frank E. Celli CEO BioHiTech Global, Inc. 80 Red Schoolhouse Road Chestnut Ridge, NY 10977 February 28, 2020 Anthony Fuller Re: Offer of Employment Dear Tony: As we discussed we are extending to you an offer of employment as the company’s Chief Administrative Officer. If you accept our offer of employment, the following terms

February 3, 2020 EX-99.1

BioHiTech Global to Provide Its Revolution Series Digesters and Data Analytics Platform to Carnival Corp in a Purchase Contract worth up to $14 Million Companies partner with a goal of reducing the cruise operator’s carbon footprint and capturing pla

Exhibit 99.1 BIOHITECH GLOBAL, Inc. 80 Red Schoolhouse Road, Suite 101 Chestnut Ridge, NY 10977 BioHiTech Global to Provide Its Revolution Series Digesters and Data Analytics Platform to Carnival Corp in a Purchase Contract worth up to $14 Million Companies partner with a goal of reducing the cruise operator’s carbon footprint and capturing plastics through an automated and natural processing of f

February 3, 2020 8-K

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 30, 2020 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S. E

January 30, 2020 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

8-K 1 tm205892d18k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 24, 2020 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (C

January 30, 2020 EX-10.1

Product and Service Supply Agreement between BioHiTech America LLC and Carnival Corporation, Carnival plc and specified operating companies dated December 18, 2019. (Certain portions of this Exhibit have been omitted) (previously filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed January 30, 2020and incorporated herein by reference).

EX-10.1 2 tm205892d1ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 In accordance with Item 601 (b)(10)(iv) certain portions, including its Attachment 1 that covers pricing and volume tiers of purchases, of this agreement have been omitted PRODUCT AND SERVICE SUPPLY AGREEMENT This Product and Service Supply Agreement (this “Agreement”) is between you (“you” or “Seller”), Carnival Corporation and each operati

November 20, 2019 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 tm1923493d18k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 20, 2019 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization)

November 20, 2019 EX-99.1

BioHiTech Global Reports Third Quarter 2019 and Provides Business Update

Exhibit 99.1 BIOHITECH GLOBAL, Inc. 80 Red Schoolhouse Road, Suite 101 Chestnut Ridge, NY 10977 BioHiTech Global Reports Third Quarter 2019 and Provides Business Update · Q3 Revenues increased 31.1% to reach $1.43 million compared to $1.09 Million in Q3 2018 · Q3 Revenue from the Company’s first HEBioT renewable resource recovery facility continued to ramp with Q3 revenue increasing by 120% sequen

November 19, 2019 10-Q

BHTG / BioHiTech Global, Inc. 10-Q - Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2019 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-36843 BIOHITECH GLOBAL

November 15, 2019 NT 10-Q

BHTG / BioHiTech Global, Inc. NT 10-Q - - NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SEC FILE NUMBER 001-36843 FORM 12b-25 CUSIP NUMBER NOTIFICATION OF LATE FILING 09074B107 (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K x Form 10-Q ☐ Form N-SAR ☐ Form N-CSR For Period Ended: September 30, 2019 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Rep

September 12, 2019 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 9, 2019 BIOHITECH GLOBAL, INC.

September 9, 2019 424B5

BIOHITECH GLOBAL, INC. 1,877,666 Shares of Common Stock

PROSPECTUS SUPPLEMENT SUBJECT TO COMPLETION Filed Pursuant to Rule 424(b)(5) (to Prospectus June 29, 2018) Registration No.

September 6, 2019 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 5, 2019 BIOHITECH GLOBAL, INC.

September 6, 2019 EX-99.1

BioHiTech Global Announces Registered Direct Offering of its Common Stock

Exhibit 99.1 BIOHITECH GLOBAL, Inc. 80 Red Schoolhouse Road, Suite 101 Chestnut Ridge, NY 10977 BioHiTech Global Announces Registered Direct Offering of its Common Stock CHESTNUT RIDGE, NY – September 6, 2019 (PRNewswire) – BioHiTech Global, Inc. (“BioHiTech” or the “Company”) (NASDAQ: BHTG), a technology and services company that provides cost-effective and sustainable waste management solutions,

September 6, 2019 EX-10.2

Placement Agent Agreement dated September 5, 2019 by and between BioHiTech Global, Inc. and Spartan Capital Securities, LLC (previously filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on September 6, 2019 and incorporated herein by reference).

Exhibit 10.2 September 5, 2019 BioHiTech Global 80 Red Schoolhouse Road, Suite 101 Chestnut Ridge, NY 10977 Attn: Frank Celli, Chief Executive Officer Dear Mr. Celli: This letter (the “Agreement”) constitutes the agreement between Spartan Capital Securities, LLC (“Spartan” or the “Placement Agent”) and BioHiTech Global, Inc. (the “Company”), that Spartan shall serve as the exclusive placement agen

September 6, 2019 EX-10.1

Form of Securities Purchase Agreement dated September 5, 2019 between BioHiTech Global, Inc. and certain purchasers (previously filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on September 6, 2019 and incorporated herein by reference).

Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of September , 2019, between BioHiTech Global, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”). WHEREAS, subject to the terms and condition

September 6, 2019 EX-10.3

Form of Placement Agent Warrant (previously filed as Exhibit 10.3 to the Company’s Current Report on Form 8-K filed on September 6, 2019 and incorporated herein by reference).

Exhibit 10.3 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGIST

September 5, 2019 424B5

BIOHITECH GLOBAL, INC. [●] Shares of Common Stock

The information in this preliminary prospectus supplement is not complete and may be changed.

August 15, 2019 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 tv5276828k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 14, 2019 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Comm

August 15, 2019 EX-99.1

BioHiTech Global Reports Second Quarter 2019 and Provides Business Update

Exhibit 99.1 BIOHITECH GLOBAL, Inc. 80 Red Schoolhouse Road, Suite 101 Chestnut Ridge, NY 10977 BioHiTech Global Reports Second Quarter 2019 and Provides Business Update · Company began revenue generating operations at the Nation’s first renewable resource recovery facility located in Martinsburg, West Virginia · Q2 recurring digester rental revenue increased by 31.9% quarter over quarter as total

August 14, 2019 10-Q

August 14, 2019

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2019 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-36843 BIOHITECH GLOBAL, INC

July 22, 2019 8-K

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 17, 2019 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-233496 (State of Organization) (Commission File Number) (I.R.S. Emplo

July 5, 2019 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 28, 2019 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S. Empl

May 16, 2019 EX-99.1

BioHiTech Global Reports First Quarter 2019 and Provides Business Update

Exhibit 99.1 BIOHITECH GLOBAL, Inc. 80 Red Schoolhouse Road, Suite 101 Chestnut Ridge, NY 10977 BioHiTech Global Reports First Quarter 2019 and Provides Business Update · At the end of Q1, the Company commenced operations at the Nation’s first renewable resource recovery facility located in Martinsburg, West Virginia · Q1 recurring revenue from the Company’s digester business increased by 10.7% qu

May 16, 2019 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 tv5218058k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 15, 2019 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commiss

May 15, 2019 EX-10.25

Form of Investor Subscription Agreement Series D Convertible Preferred Stock (previously filed as Exhibit 10.25 on the Quarterly Report on Form 10-Q filed on May 15, 2019 and incorporated herein by reference).

Exhibit 10.25 BIOHITECH GLOBAL, INC. INVESTOR SUBSCRIPTION AGREEMENT (the “Subscription Agreement”) between BIOHITECH GLOBAL, INC., a Delaware corporation (the “Company”) and the person or persons executing this Agreement on the execution page hereof (the “Subscriber”). All documents mentioned herein are incorporated by reference. 1. Description of the Offering. This Subscription Agreement is for

May 15, 2019 EX-4.9

Certificate of Amendment of Certificate of Designation of Series D Convertible Preferred Stock (previously filed as Exhibit 4.9 of the Quarterly Report on Form 10-Q filed on May 15, 2019 and incorporated herein by reference).

Exhibit 4.9 CERTIFICATE OF DESIGNATION OF SERIES D CONVERTIBLE PREFERRED STOCK OF BIOHITECH GLOBAL, INC. BioHiTech Global, Inc., a corporation organized and existing under the laws of the State of Delaware ("Company"), hereby certifies that the Board of Directors of the Company (the "Board of Directors" or the "Board"), pursuant to authority of the Board of Directors as required by applicable corp

May 15, 2019 EX-4.8

Certificate of Designation of Series D Convertible Preferred Stock (previously filed as Exhibit 4.8 of the Quarterly Report on Form 10-Q filed on May 15, 2019 and incorporated herein by reference).

EX-4.8 2 tv520700ex4-8.htm EXHIBIT 4.8 Exhibit 4.8 CERTIFICATE OF DESIGNATION OF SERIES D CONVERTIBLE PREFERRED STOCK OF BIOHITECH GLOBAL, INC. BioHiTech Global, Inc., a corporation organized and existing under the laws of the State of Delaware ("Company"), hereby certifies that the Board of Directors of the Company (the "Board of Directors" or the "Board"), pursuant to authority of the Board of D

May 15, 2019 EX-10.26

Form of Common Stock Warrant Issued with Series D Convertible Preferred Stock (previously filed as Exhibit 10.26 on Quarterly Report on Form 10-Q filed on May 15, 2019 and incorporated herein by reference).

EX-10.26 5 tv520700ex10-26.htm EXHIBIT 10.26 Exhibit 10.26 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE O

May 15, 2019 10-Q

May 15, 2019

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2019 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-36843 BIOHITECH GLOBAL, IN

April 29, 2019 DEF 14A

our Definitive Proxy Statement filed on April 29, 2019.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive

April 2, 2019 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 tv5179288k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 1, 2019 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commis

April 2, 2019 EX-99.1

BioHiTech Global Sees Full Year 2019 Revenue Increasing 198% to $10 Million as Its Martinsburg HEBioT Resource Recovery Facility Commences Commercial Operation

EX-99.1 2 tv517928ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 BIOHITECH GLOBAL, Inc. 80 Red Schoolhouse Road, Suite 101 Chestnut Ridge, NY 10977 FOR IMMEDIATE RELEASE BioHiTech Global Sees Full Year 2019 Revenue Increasing 198% to $10 Million as Its Martinsburg HEBioT Resource Recovery Facility Commences Commercial Operation CHESTNUT RIDGE, NY – April 2, 2019 – BioHiTech Global, Inc. ("BioHiTech" or the

April 1, 2019 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 tv5177868k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 1, 2019 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commis

April 1, 2019 EX-99.1

BioHiTech Global Reports Full Year 2018 Results

Exhibit 99.1 BIOHITECH GLOBAL, Inc. 80 Red Schoolhouse Road, Suite 101 Chestnut Ridge, NY 10977 BioHiTech Global Reports Full Year 2018 Results · Company’s HEBioT development subsidiary acquired majority control of the Nation’s first resource recovery facility located in Martinsburg, West Virginia · Received $3.5 million in cash and $2 million in assets from Kinderhook Industries backed Gold Medal

April 1, 2019 10-K

our Annual Report on Form 10-K for the fiscal year ended December 31, 2018, filed with the SEC on April 1, 2019;

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36843 BioHiTech Global,

April 1, 2019 EX-21.1

List of Subsidiaries.*

Exhibit 21.1 Subsidiaries Ownership Subsidiaries of BioHiTech Global, Inc.: Bio Hi Tech America, LLC (Delaware limited liability company) 100 % BioHiTech Europe Limited (A private company limited by shares registered in England and Wales) 100 % E.N.A Renewables LLC (Delaware limited liability company) 100 % BHT Financial LLC (Delaware limited liability company) 100 % Apple Valley Waste Conversions

March 4, 2019 EX-99.6

BIOHITECH GLOBAL, INC. UNAUDITED PRO FORMA CONDENCED COMBINED FINANCIAL INFORMATION

Exhibit 99.6 BIOHITECH GLOBAL, INC. UNAUDITED PRO FORMA CONDENCED COMBINED FINANCIAL INFORMATION On November 28, 2018, BioHiTech Global, Inc. (“BioHiTech”, the “Company” or “BHTG”), the registrant, entered into a definitive agreement (the “MIPS”) with Entsorga USA, Inc. (“EUSA”) whereby EUSA agreed to sell, transfer and convey to BioHiTech 2,687 common units of Entsorga West Virginia, LLC (“EWV”)

March 4, 2019 8-K/A

Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

8-K/A 1 tv5151688ka.htm FORM 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 14, 2018 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organizati

February 28, 2019 8-K/A

Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

8-K/A 1 tv5146068ka.htm FORM 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 14, 2018 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organizati

February 28, 2019 EX-99.3

1

Exhibit 99.3 UNAUDITED FINANCIAL STATEMENTS ENTSORGA WEST VIRGINIA LLC (A LIMITED LIABILITY COMPANY) SEPTEMBER 30, 2018 ENTSORGA WEST VIRGINIA LLC (A LIMITED LIABILITY COMPANY) CONTENTS Page Financial Statements: Balance Sheets 1 Statements of Operations and Members’ Equity 2 Statements of Cash Flows 3 Notes to the Financial Statements 4 - 8 ENTSORGA WEST VIRGINIA LLC (A LIMITED LIABILITY COMPANY)

February 28, 2019 EX-99.1

INDEPENDENT AUDITOR'S REPORT

Exhibit 99.1 AUDITED FINANCIAL STATEMENTS ENTSORGA WEST VIRGINIA LLC (A LIMITED LIABILITY COMPANY) DECEMBER 31, 2016 ENTSORGA WEST VIRGINIA LLC (A LIMITED LIABILITY COMPANY) CONTENTS Page Independent Auditor's Report 1 Financial Statements: Balance Sheet 2 Statement of Operations and Members’ Equity 3 Statement of Cash Flows 4 Notes to the Financial Statements 5 - 8 INDEPENDENT AUDITOR'S REPORT To

February 28, 2019 EX-99.2

INDEPENDENT AUDITOR'S REPORT

Exhibit 99.2 AUDITED FINANCIAL STATEMENTS ENTSORGA WEST VIRGINIA LLC (A LIMITED LIABILITY COMPANY) DECEMBER 31, 2017 ENTSORGA WEST VIRGINIA LLC (A LIMITED LIABILITY COMPANY) CONTENTS Page Independent Auditor's Report 1 Financial Statements: Balance Sheet 2 Statement of Operations and Members’ Equity 3 Statement of Cash Flows 4 Notes to the Financial Statements 5 - 9 INDEPENDENT AUDITOR'S REPORT To

December 28, 2018 S-3

Power of Attorney (included on signature page)

As filed with the Securities and Exchange Commission on December 28, 2018 Registration Statement No.

December 20, 2018 8-K

Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 14, 2018 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S.

December 20, 2018 EX-99.5

Kinderhook Industries Portfolio Company Contributes Cash and Assets Totalling $5.5 Million for a 40% Stake in a Newly Formed BioHiTech Subsidiary New subsidiary now holds a 78% ownership stake in the Martinsburg HEBioT facility and will serve as a pl

EX-99.5 3 tv509628ex99-5.htm EXHIBIT 99.5 Exhibit 99.5 BIOHITECH GLOBAL, Inc. 80 Red Schoolhouse Road, Suite 101 Chestnut Ridge, NY 10977 FOR IMMEDIATE RELEASE Kinderhook Industries Portfolio Company Contributes Cash and Assets Totalling $5.5 Million for a 40% Stake in a Newly Formed BioHiTech Subsidiary New subsidiary now holds a 78% ownership stake in the Martinsburg HEBioT facility and will ser

December 20, 2018 EX-99.4

CONTRIBUTION AND TRANSACTION AGREEMENT

Exhibit 99.4 CONTRIBUTION AND TRANSACTION AGREEMENT This Contribution and Transaction Agreement (this “Agreement”), dated as of December 14, 2018, is by and among Refuel America, LLC, a Delaware limited liability company (the “Company”), Gold Medal Group, LLC, a Delaware limited liability company (“Gold Medal”), BioHitech Global, Inc., a Delaware corporation (“BHT”), E.N.A. Renewables, LLC (f/k/a

December 18, 2018 8-K

Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 14, 2018 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S.

December 18, 2018 EX-4.1

Certificate of Designation of Series E Convertible Preferred Stock (previously filed as Exhibit 4.1 of the Current Report on Form 8-K filed on December 18, 2018 and incorporated herein by reference).

Exhibit 4.1 CERTIFICATE OF DESIGNATION OF RIGHTS, REFERENCES AND PRIVILEGES OF SERIES E CONVERTIBLE PREFERRED STOCK OF BIOHITECH GLOBAL, INC. To Be Designated Series E Convertible Preferred Stock The undersigned DOES HEREBY CERTIFY that the following resolution was duly adopted by the Board of Directors (the “Board of Directors”) of BioHiTech Global, Inc., a Delaware corporation (the “Company”), a

December 18, 2018 EX-99.5

BioHiTech Global Completes Acquisition to Become the Largest Owner of the Nation’s First HEBioT Renewable Resource Recovery Facility Company sees the facility’s operations adding $7 million of annual high margin revenue by processing municipal solid

Exhibit 99.5 BIOHITECH GLOBAL, Inc. 80 Red Schoolhouse Road, Suite 101 Chestnut Ridge, NY 10977 FOR IMMEDIATE RELEASE BioHiTech Global Completes Acquisition to Become the Largest Owner of the Nation’s First HEBioT Renewable Resource Recovery Facility Company sees the facility’s operations adding $7 million of annual high margin revenue by processing municipal solid waste into an EPA approved solid

December 4, 2018 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

8-K 1 tv5084718k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 28, 2018 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Co

December 4, 2018 EX-99.2

BioHiTech Global Signs Definitive Agreement to Increase Its Ownership Stake in the Nation's First HEBioT Renewable Resource Recovery Facility

EX-99.2 3 tv508471ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 BioHiTech Global Signs Definitive Agreement to Increase Its Ownership Stake in the Nation's First HEBioT Renewable Resource Recovery Facility The facility is expected to commence operations in December and add $7 million of annual high margin revenue by processing municipal solid waste into an EPA approved solid recovered fuel CHESTNUT RIDGE,

December 4, 2018 EX-99.1

MEMBERSHIP INTEREST PURCHASE AND SALE AGREEMENT by and among ENTSORGA USA, INC., (as “Seller”) BIOHITECH GLOBAL, INC. (as “Purchaser”) ENTSORGA WEST VIRGINIA LLC (as “Company”) For the purchase of Common Units of Entsorga West Virginia LLC Dated: Eff

Exhibit 99.1 MEMBERSHIP INTEREST PURCHASE AND SALE AGREEMENT by and among ENTSORGA USA, INC., (as “Seller”) BIOHITECH GLOBAL, INC. (as “Purchaser”) and ENTSORGA WEST VIRGINIA LLC (as “Company”) For the purchase of Common Units of Entsorga West Virginia LLC Dated: Effective as of November 28, 2018 MEMBERSHIP INTEREST PURCHASE AND SALE AGREEMENT THIS MEMBERSHIP INTEREST PURCHASE AND SALE AGREEMENT (

November 14, 2018 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 14, 2018 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S.

November 14, 2018 EX-99.1

BioHiTech Global Reports Third Quarter 2018 Financial Results Q3 2018 revenues increase by 65.8% with gross profit increasing by 282.8%

EX-99.1 2 tv507285ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 BIOHITECH GLOBAL, Inc. 80 Red Schoolhouse Road Suite 101 Chestnut Ridge, NY 10977 BioHiTech Global Reports Third Quarter 2018 Financial Results Q3 2018 revenues increase by 65.8% with gross profit increasing by 282.8% CHESTNUT RIDGE, NY – November 14, 2018 – BioHiTech Global, Inc. (“BioHiTech” or the “Company”) (NASDAQ: BHTG), a technology and

November 14, 2018 10-Q

November 14, 2018

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2018 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-36843 BIOHITECH GLOBAL

August 15, 2018 EX-99.1

BioHiTech Global Reports Second Quarter 2018 Financial Results Q2 2018 revenues increase by 65.5% with gross profit increasing by 185.4%

Exhibit 99.1 BIOHITECH GLOBAL, Inc. 80 Red Schoolhouse Road, Suite 101 Chestnut Ridge, NY 10977 BioHiTech Global Reports Second Quarter 2018 Financial Results Q2 2018 revenues increase by 65.5% with gross profit increasing by 185.4% CHESTNUT RIDGE, NY – August 15, 2018 – BioHiTech Global, Inc. (“BioHiTech” or the “Company”) (NASDAQ: BHTG), a technology and services company that provides cost-effec

August 15, 2018 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 15, 2018 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S. Em

August 14, 2018 10-Q

BHTG / BioHiTech Global, Inc. 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2018 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-36843 BIOHITECH GLOBAL, INC

July 6, 2018 CORRESP

BHTG / BioHiTech Global, Inc. CORRESP

BioHiTech Global, Inc. 80 Red Schoolhouse Road Chestnut Ridge, NY 10977 (845) 262-1081 www.biohitech.com July 6, 2018 Via Edgar Only United States Securities and Exchange Commission Mail Stop 6010 Washington, D.C. 20549 Re: BioHiTech Global, Inc. Registration Statement on Form S-3 Filed on June 29, 2018 File No. 333-225999 To Whom It May Concern: Please be advised that the undersigned is the duly

June 29, 2018 S-3

BHTG / BioHiTech Global, Inc. FORM S-3

As filed with the Securities and Exchange Commission on June 29, 2018 Registration Statement No.

June 29, 2018 EX-4.3

Form of Indenture relating to the issuance from time to time in one or more series of debentures, notes, bonds or other evidences of indebtedness (1)

Exhibit 4.3 BIOHITECH GLOBAL, INC. AND , TRUSTEE INDENTURE DATED AS OF , 2018 DEBT SECURITIES BIOHITECH GLOBAL, INC. RECONCILIATION AND TIE BETWEEN TRUST INDENTURE ACT OF 1939 AND INDENTURE, DATED AS OF , 2018 Section of Trust Indenture Act of 1939 Section(s) of Indenture § 310(a)(1) 609 (a)(2) 609 (a)(3) Not Applicable (a)(4) Not Applicable (a)(5) 609 (b) 608, 610 § 311(a) 613 (b) 613 (c) Not App

June 22, 2018 8-K

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 20, 2018 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S. Empl

June 11, 2018 S-8

BHTG / BioHiTech Global, Inc. S-8

S-8 1 tv496115s8.htm S-8 As filed with the Securities and Exchange Commission on June 11, 2018 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 BIOHITECH GLOBAL, INC. (Exact name of registrant as specified in its charter) Delaware 46-2336496 (State or other jurisdiction of incorporation or

June 11, 2018 EX-4.1

Specimen stock certificate for common stock (previously filed as Exhibit 4.1 to the Registration Statement on Form S-8 filed on June 11, 2018 and incorporated herein by reference).

Exhibit 4.1 Specimen Common Stock Certificate

May 16, 2018 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 16, 2018 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S. Emplo

May 16, 2018 EX-99.1

BioHiTech Global Reports First Quarter 2018 Results

Exhibit 99.1 BIOHITECH GLOBAL, Inc. 80 Red Schoolhouse Road, Suite 101 Chestnut Ridge, NY 10977 BioHiTech Global Reports First Quarter 2018 Results · Q1 2018 revenue from rental, service and maintenance increased 23% with total revenues increasing by 9% · Q1 2018 gross profit increased by 42% while operating loss narrowed by 23% due to improving economies of scale CHESTNUT RIDGE, NY – May 16, 2018

May 15, 2018 10-Q

May 15, 2018

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2018 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-36843 BIOHITECH GLOBAL, IN

April 27, 2018 DEF 14A

BHTG / BioHiTech Global, Inc. DEFINITIVE PROXY STATEMENT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive

April 5, 2018 8-A12B

The description of our common stock contained in our Registration Statement on Form 8-A filed on April 5, 2018, including any amendments or reports filed for the purpose of updating that description.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 BioHiTech Global, Inc. (Exact name of registrant as specified in its charter) Delaware 46-2336496 (State of incorporation or organization) (I.R.S. Employer Identification No.) 80 Red Schoolhouse Rd

April 5, 2018 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 30, 2018 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S. Emp

April 4, 2018 8-K

April 4, 2018

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 2, 2018 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S. Empl

April 4, 2018 EX-99.1

BioHiTech Global Reports Full Year 2017 Results

Exhibit 99.1 BIOHITECH GLOBAL, Inc. 80 Red Schoolhouse Road, Suite 101 Chestnut Ridge, NY 10977 BioHiTech Global Reports Full Year 2017 Results · Company launched its new Revolution Series Digesters and began shipping customer orders in September 2017 · Recurring revenue from Digester rental and maintenance contracts increased by 18% as the total future minimum contractual customer rental revenue

April 2, 2018 EX-21.1

List of Subsidiaries

Exhibit 21.1 Subsidiaries Ownership Bio Hi Tech America, LLC (Delaware limited liability Company) 100% BioHiTech Europe Limited (A private company limited by shares registered in England and Wales) 100% E.N.A Renewables LLC (Formerly Entsorga North America, LLC) (Delaware limited liability Company) 100% Apple Valley Waste Conversions, LLC (Delaware limited liability Company) 31% BHT Financial LLC

April 2, 2018 10-K

Our Annual Report on Form 10-K for the fiscal year ended December 31, 2017, filed with the Commission on April 2, 2018;

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36843 BioHiTech Global,

February 8, 2018 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 2, 2018 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S. E

February 8, 2018 EX-99.1

BioHiTech Global Secures New $1M Credit Facility with Comerica Bank

Exhibit 99.1 BIOHITECH GLOBAL, Inc. 80 Red Schoolhouse Road, Suite 101 Chestnut Ridge, NY 10977 FOR IMMEDIATE RELEASE BioHiTech Global Secures New $1M Credit Facility with Comerica Bank CHESTNUT RIDGE, NY ? February 8, 2018 ? BioHiTech Global, Inc. (?BioHiTech? or the ?Company?) (OTCQB: BHTG), a technology and services company that provides cost-effective and sustainable waste management solutions

February 8, 2018 EX-10.2

Master Revolving Note in favor of Comerica Bank, dated February 2, 2018 (previously filed as Exhibit 10.2 of the Current Report on Form 8-K filed on February 8, 2018 and incorporated herein by reference).

Exhibit 10.2 Master Revolving Note AMOUNT $1,000,000.00 NOTE DATE February 2, 2018 MATURITY DATE January 1, 2020 1. On or before the maturity date set forth above (the "Maturity Date"), FOR VALUE RECEIVED, the undersigned promise(s) to pay to the order of COMERICA BANK (herein called "Bank"), at any office of the Bank in the State of Michigan, the principal sum of ONE MILLION and 00/100 DOLLARS ($

February 8, 2018 EX-10.3

First Amendment to Original Issue Discount Convertible Promissory Note between the Company and holders of the Series C Original Issue Discount Convertible Promissory Notes, dated February 2, 2018 (previously filed as Exhibit 10.3 of the Current Report on Form 8-K filed on February 8, 2018 and incorporated herein by reference).

Exhibit 10.3 [FORM OF] FIRST AMENDMENT TO ORIGINAL ISSUE DISCOUNT CONVERTIBLE PROMISSORY NOTE This First Amendment to Original Issue Discount Convertible Promissory Note (the ?Amendment?) is dated , 2018 by and between BIOHITECH GLOBAL, INC., a publicly-owned Delaware corporation (the ?Company?) having its principal offices at 80 Red Schoolhouse Road, Suite 101, Chestnut Ridge, NY 10977 and the pe

February 8, 2018 EX-10.4

Common Stock Purchase Warrant in favor of the holders of the Series C Original Issue Discount Convertible Promissory Notes dated February 2, 2018 (previously filed as Exhibit 10.4 of the Current Report on Form 8-K filed on February 8, 2018 and incorporated herein by reference).

Exhibit 10.4 THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?ACT?), OR THE SECURITIES LAWS OF ANY STATE. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF A REGISTRATION STATEMENT IN EFFECT WITH RESPECT TO SUCH SECURITIES UNDER SUCH ACT AND QUALIFICATION

February 8, 2018 EX-10.1

Credit Agreement between Comerica Bank and BHT Financial, LLC, dated February 2, 2018 (previously filed as Exhibit 10.1 of the Current Report on Form 8-K filed on February 8, 2018 and incorporated herein by reference).

Exhibit 10.1 Execution Copy CREDIT AGREEMENT This Credit Agreement is entered into as of February 2, 2018, by and between Comerica Bank (?Bank?) and BHT Financial LLC, a Delaware limited liability company (?Borrower?). In consideration of all present and future loans and credit from time to time made available by Bank to or in favor of Borrower, and in consideration of all present and future Indeb

February 6, 2018 EX-10.4

Certificate of Designation of Series C Convertible Preferred Stock (previously filed as Exhibit 10.4 of the Current Report on Form 8-K filed on February 6, 2018 and incorporated herein by reference).

Exhibit 10.4 CERTIFICATE OF DESIGNATION OF SERIES C CONVERTIBLE PREFERRED STOCK OF BIOHITECH GLOBAL, INC. BioHiTech Global, Inc., a corporation organized and existing under the laws of the State of Delaware ("Company"), hereby certifies that the Board of Directors of the Company (the "Board of Directors" or the "Board"), pursuant to authority of the Board of Directors as required by applicable cor

February 6, 2018 EX-10.1

Note Purchase and Security Agreement between the Company and Michaelson Capital Special Finance Fund II, L.P., dated February 2, 2018 (previously filed as Exhibit 10.1 of the Current Report on Form 8-K filed on February 6, 2018 and incorporated herein by reference).

Exhibit 10.1 NOTE PURCHASE AND SECURITY AGREEMENT DATED AS OF February 2, 2018 BY and AMONG MICHAELSON CAPITAL SPECIAL FINANCE FUND II, L.P., as Purchaser and BioHiTech Global, Inc., BHT FINANCIAL, LLC, BioHiTech America, LLC, BioHiTech Europe, PLC, E.N.A. Renewables, LLC, AND NEW WINDSOR RESOURCE RECOVERY, LLC, as BorrowerS TABLE OF CONTENTS Page 1. Note and Share Purchase and Sale 1 1.1 Term Not

February 6, 2018 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 2, 2018 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S. E

February 6, 2018 EX-10.3

Securities Exchange and Note Purchase Agreement between the Company and Frank E. Celli, dated February 2, 2018 (previously filed as Exhibit 10.3 of the Current Report on Form 8-K filed on February 6, 2018 and incorporated herein by reference).

Exhibit 10.3 SECURITIES EXCHANGE AND NOTE PURCHASE AGREEMENT This Debt Exchange Agreement and Release (this ?Agreement?) is made and entered into as of , 2018 (the ?Effective Date?), by and among BioHiTech Global, Inc., a Delaware corporation (?BHTG?), BioHiTech America LLC, a Delaware limited liability company (?BHTA?) wholly owned by BHTG (BHTG and BHTA collectively and individually referred to

February 6, 2018 EX-10.5

Junior Promissory Note in favor of Frank E. Celli, dated February 2, 2018 (previously filed as Exhibit 10.5 of the Current Report on Form 8-K filed on February 6, 2018 and incorporated herein by reference).

Exhibit 10.5 PAYMENT OF THE INDEBTEDNESS EVIDENCED BY THIS INSTRUMENT OR DOCUMENT AND THE RIGHTS OF THE HOLDER HEREOF ARE SUBORDINATED AND SUBJECT TO THE RIGHTS OF THE SENIOR HOLDER AS DEFINED IN AND ACCORDING TO THE TERMS OF A SUBORDINATION AGREEMENT, DATED FEBRUARY 2, 2018, AMONG BIOHITECH GLOBAL, INC. AND ITS SUBSIDIARIES, THE HOLDER AND MICHAELSON CAPITAL SPECIAL FINANCE FUND II, L.P. JUNIOR P

February 6, 2018 EX-99.1

BioHiTech Global Completes $5M Non-Convertible Senior Secured Debt Financing

Exhibit 99.1 BIOHITECH GLOBAL, Inc. 80 Red Schoolhouse Road, Suite 101 Chestnut Ridge, NY 10977 FOR IMMEDIATE RELEASE BioHiTech Global Completes $5M Non-Convertible Senior Secured Debt Financing CHESTNUT RIDGE, NY ? February 6, 2018 ? BioHiTech Global, Inc. (?BioHiTech? or the ?Company?) (OTCQB: BHTG), a technology and services company that provides cost-effective and sustainable waste management

February 6, 2018 EX-10.2

Senior Secured Term Note in favor of Michaelson Capital Special Finance Fund II, L.P., dated February 2, 2018 (previously filed as Exhibit 10.2 of the Current Report on Form 8-K filed on February 6, 2018 and incorporated herein by reference).

Exhibit 10.2 SENIOR SECURED TERM NOTE $5,000,000.00 , 2018 (the “Issuance Date”) FOR VALUE RECEIVED, BioHiTech Global, Inc., a Delaware corporation (“BHT Global”), BHT Financial, LLC, a Delaware limited liability company, BioHiTech America, LLC, a Delaware limited liability company, BioHiTech Europe, PLC, a United Kingdom private limited company, E.N.A. Renewables, LLC, a Delaware limited liabilit

January 30, 2018 EX-99.1

BioHiTech Global Partners with Kinderhook Industries to Create a “Next Generation” Environmental Services Platform Company

Exhibit 99.1 BIOHITECH GLOBAL, INC. 80 RED SCHOOLHOUSE ROAD, SUITE 101 CHESTNUT RIDGE, NY 10977 FOR IMMEDIATE RELEASE BioHiTech Global Partners with Kinderhook Industries to Create a “Next Generation” Environmental Services Platform Company · Companies jointly acquire Gold Medal Services, a New Jersey based solid waste collection business servicing the Philadelphia and Southern NJ Markets · Gold M

January 30, 2018 EX-10.1

Membership Interest Purchase Agreement for Gold Medal Group, LLC, dated January 25, 2018 (previously filed as Exhibit 10.1 of the Current Report on Form 8-K filed on January 30, 2018 and incorporated herein by reference).

Exhibit 10.1 MEMBERSHIP INTEREST PURCHASE AGREEMENT This Membership Interest Purchase Agreement (this ?Agreement?) is effective as of January 25, 2018, by and between E.N.A. Renewables, LLC, a Delaware limited liability company (?Buyer?), BioHiTech Global, Inc., a Delaware corporation and parent of the Buyer (the ?Parent?), [] and [], each an individual (collectively, the ?Sellers?) and Gold Medal

January 30, 2018 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

8-K 1 tv4843038k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 25, 2018 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Com

January 4, 2018 EX-4.2

Form of Warrant (previously filed as Exhibit 4.2 of the Current Report on Form 8-K filed on January 4, 2018 and incorporated herein by reference).

EX-4.2 3 tv482637ex4-2.htm EXHIBIT 4.2 Exhibit 4.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN

January 4, 2018 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 28, 2017 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S.

January 4, 2018 EX-4.1

Certificate of Designation of Series B Convertible Preferred Stock (previously filed as Exhibit 4.1 of the Current Report on Form 8-K filed on January 4, 2018 and incorporated herein by reference).

EX-4.1 2 tv482637ex4-1.htm EXHIBIT 4.1 Exhibit 4.1 CERTIFICATE OF DESIGNATION OF SERIES B CONVERTIBLE PREFERRED STOCK OF BIOHITECH GLOBAL, INC. BioHiTech Global, Inc., a corporation organized and existing under the laws of the State of Delaware ("Company"), hereby certifies that the Board of Directors of the Company (the "Board of Directors" or the "Board"), pursuant to authority of the Board of D

January 4, 2018 EX-10.1

Form of Securities Purchase Agreement

Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this ?Agreement?) is dated as of [], between BioHiTech Global, Inc., a Delaware corporation (the ?Company?), and each Purchaser identified on the signature hereto (each including its successors and assigns (a ?Purchaser?, and collectively the ?Purchasers?). WHEREAS, subject to the terms and conditions set forth in this

December 21, 2017 8-K

BHTG / BioHiTech Global, Inc. FORM 8-K (Current Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 15, 2017 BIOHITECH GLOBAL, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organization) (Commission File Number) (I.R.S.

November 15, 2017 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 15, 2017 BIOHITECH GLOBAL, INC. (formerly known as Swift Start Corp.) (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-2336496 (State of Organizat

November 15, 2017 EX-99.1

BIOHITECH GLOBAL, Inc. | 80 Red Schoolhouse Road, Suite 101 | Chestnut Ridge, NY 10977

Exhibit 99.1 BIOHITECH GLOBAL, Inc. | 80 Red Schoolhouse Road, Suite 101 | Chestnut Ridge, NY 10977 FOR IMMEDIATE RELEASE BioHiTech Global Reports Third Quarter 2017 Results ? Q3 2017 recurring revenue from rental, service and maintenance increased by 15.8% to $415,000 with total revenue rising 5.3% to $656,000 ? Company commenced delivery of its Revolution Series Digesters late in Q3 2017 CHESTNU

November 14, 2017 10-Q

November 14, 2017

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2017 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-36843 BIOHITECH GLOBAL

November 3, 2017 EX-4.1

Certificate of Designation of Series A Convertible Preferred Stock (previously filed as Exhibit 4.1 of the Current Report on Form 8-K filed on November 3, 2017 and incorporated herein by reference).

Exhibit 4.1 CERTIFICATE OF DESIGNATION OF SERIES A CONVERTIBLE PREFERRED STOCK OF BIOHITECH GLOBAL, INC. BioHiTech Global, Inc., a corporation organized and existing under the laws of the State of Delaware ("Company"), hereby certifies that the Board of Directors of the Company (the "Board of Directors" or the "Board"), pursuant to authority of the Board of Directors as required by applicable corp

November 3, 2017 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 30, 2017 BIOHITECH GLOBAL, INC. (formerly known as Swift Start Corp.) (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-233496 (State of Organizatio

November 3, 2017 EX-4.2

Form of Common Stock Purchase Warrant

Exhibit 4.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR T

November 3, 2017 EX-10.1

Form of Securities Purchase Agreement

Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this ?Agreement?) is dated as of October , 2017, between BioHiTech Global, Inc., a Delaware corporation (the ?Company?), and [] (the ?Purchaser?). WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the ?Securities Act?), and

November 2, 2017 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 1, 2017 BIOHITECH GLOBAL, INC. (formerly known as Swift Start Corp.) (Exact Name of Registrant as Specified in its Charter) Delaware 001-36843 46-233496 (State of Organizatio

November 2, 2017 EX-10.1

Technology License Agreement between BioHiTech Global, Inc., E.N.A. Renewables LLC and Entsorgafin S.P.A., dated November 1, 2017 (previously filed as Exhibit 10.1 of the Current Report on Form 8-K filed on November 2, 2017 and incorporated herein by reference).

Exhibit 10.1 TECHNOLOGY LICENSE AGREEMENT among ENTSORGAFIN S.P.A., E.N.A RENEWABLES, LLC, and BIOHITECH GLOBAL, INC. Dated as of November 1, 2017 This TECHNOLOGY LICENSE AGREEMENT (the ?Agreement?), dated as of November 1, 2017 (the ?Effective Date?), among Entsorgafin S.P.A., an Italian joint stock company (?Licensor?), E.N.A. Renewables, LLC, a Delaware limited liability company (?Licensee?), a

November 2, 2017 EX-99.1

BioHiTech Global Completes Acquisition of First HEBioTÔ Renewable Waste Facility License from Entsorgafin S.P.A. for a Combination of $6.1 Million in Cash and Common Stock Transaction expected to boost balance sheet assets by $5.2 million as Company

Exhibit 99.1 BIOHITECH GLOBAL, Inc. 80 Red Schoolhouse Road, Suite 101 Chestnut Ridge, NY 10977 FOR IMMEDIATE RELEASE BioHiTech Global Completes Acquisition of First HEBioT? Renewable Waste Facility License from Entsorgafin S.P.A. for a Combination of $6.1 Million in Cash and Common Stock Transaction expected to boost balance sheet assets by $5.2 million as Company begins preparations to meet qual

November 2, 2017 EX-10.2

Registration Rights Agreement between BioHiTech Global, Inc., E.N.A. Renewables LLC and Entsorgafin S.p.A., dated November 1, 2017 (previously filed as Exhibit 10.2 of the Current Report on Form 8-K filed on November 2, 2017 and incorporated herein by reference).

Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this ?Agreement?) is made and entered into as of November 1, 2017 by and among BioHiTech Global, Inc., a Delaware corporation (the ?Company?), and Entsorgafin S.P.A., a joint stock company duly incorporated and validly existing under the Laws of Italy (the ?Seller?). This Agreement is being entered into pursuant to the

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista